Stock Quote (NASDAQ: NSTG)
Price:
15.92
Change:
+ 0.10
Day High:
16.00
Day Low:
15.59
Volume:
131,428
4:00 PM ET on Apr 29, 2016
Delayed at least 20 minutes.
Provided by eSignal.


Search Investor Relations

Press Releases

All Releases
View Summary PRESS RELEASEApr 27, 2016
NanoString Technologies to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
read more
View Summary PRESS RELEASEApr 18, 2016
NanoString Technologies Presents Proof-of-Concept Data for Multiplexed Digital IHC in Tumor Tissues at AACR Meeting
read more
View Summary PRESS RELEASEApr 14, 2016
NanoString Technologies Unveils New nCounter Vantage™ Assays to Power Cancer Research With 3D Biology™
read more
View Summary PRESS RELEASEApr 13, 2016
NanoString Technologies to Release First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5, 2016
read more
View Summary PRESS RELEASEApr 11, 2016
NanoString Technologies and HalioDx Enter Into Collaboration Agreement to Jointly Develop and Commercialize Novel Gene Expression Assays in Immuno-oncology
read more
View Summary PRESS RELEASEMar 21, 2016
NanoString Technologies Receives Favorable Final Local Coverage Determination by Noridian Healthcare Solutions for Its Prosigna Breast Cancer Assay
read more
View Summary PRESS RELEASEMar 10, 2016
NanoString Technologies and Cell Signaling Technology Announce Agreement to Expand Suite of 3D Biology Assays
read more
View Summary PRESS RELEASEFeb 29, 2016
NanoString Technologies Releases Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Outlook
read more
View Summary PRESS RELEASEFeb 29, 2016
NanoString Technologies and Merck Expand Collaboration to Develop and Commercialize Novel Diagnostic Test to Predict Response to KEYTRUDA® (pembrolizumab)
read more
View Summary PRESS RELEASEFeb 22, 2016
NanoString Technologies to Present at the Cowen and Company 36th Annual Health Care Conference
read more
View Summary PRESS RELEASEFeb 12, 2016
NanoString Technologies to Release Fourth Quarter 2015 Financial Results and Host Conference Call on Monday, February 29, 2016
read more
View Summary PRESS RELEASEFeb 11, 2016
NanoString Technologies Presents Proof-of-Concept Data for Novel Massively Parallel Single Molecule Sequencing Chemistry at AGBT Meeting
read more
View Summary PRESS RELEASEFeb 09, 2016
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients
read more
View Summary PRESS RELEASEJan 27, 2016
NanoString Technologies to Present at the Leerink Partners 5th Annual Global Healthcare Conference
read more
View Summary PRESS RELEASEJan 10, 2016
NanoString Technologies Provides Preliminary Operational and Financial Results for 2015
read more
View Summary PRESS RELEASEJan 07, 2016
NanoString Technologies Enters Into Collaboration Agreement With Medivation and Astellas to Develop Novel Companion Diagnostic Test
read more
View Summary PRESS RELEASEDec 23, 2015
NanoString Technologies to Present at J.P. Morgan 34th Annual Healthcare Conference
read more
View Summary PRESS RELEASEDec 07, 2015
NanoString Technologies Announces Eleven Prosigna/PAM50 Presentations at the 2015 CTRC-AACR San Antonio Breast Cancer Symposium
read more
View Summary PRESS RELEASENov 05, 2015
NanoString Technologies to Present at Canaccord Genuity Medical Technology and Diagnostics Forum
read more
View Summary PRESS RELEASENov 05, 2015
NanoString Technologies Expands 3D Biology Portfolio With the Commercial Launch of Seven New nCounter PanCancer Profiles to Deeply Probe Cancer Biology
read more
Showing 1-20 of 154 Page: 1 2 3 4 5 ... 8  Next 20